752 reports of this reaction
2.4% of all NICOTINE POLACRILEX MINI reports
#3 most reported adverse reaction
OVERDOSE is the #3 most commonly reported adverse reaction for NICOTINE POLACRILEX MINI, manufactured by AmerisourceBergen (Good Neighbor Pharmacy) 46122. There are 752 FDA adverse event reports linking NICOTINE POLACRILEX MINI to OVERDOSE. This represents approximately 2.4% of all 31,749 adverse event reports for this drug.
Patients taking NICOTINE POLACRILEX MINI who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is a less commonly reported adverse event for NICOTINE POLACRILEX MINI, but still significant enough to appear in the safety profile.
In addition to overdose, the following adverse reactions have been reported for NICOTINE POLACRILEX MINI:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 752 FDA reports for NICOTINE POLACRILEX MINI. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 2.4% of all adverse event reports for NICOTINE POLACRILEX MINI, making it one of the most commonly reported side effect.
If you experience overdose while taking NICOTINE POLACRILEX MINI, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.